Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy (Nimotuzumab)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2010 by Fudan University.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Shanghai Chest Hospital
Shanghai Pulmonary Hospital, Shanghai, China
RenJi Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Information provided by:
Fudan University
ClinicalTrials.gov Identifier:
NCT01402180
First received: July 25, 2011
Last updated: NA
Last verified: November 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)